Mo D - Search Results

1

A tRNA fragment, 5'-tiRNA^Val, suppresses the Wnt/β-catenin signaling pathway by targeting FZD3 in breast cancer.

Mo D, Jiang P, Yang Y, Mao X, Tan X, Tang X, Wei D, Li B, Wang X, Tang L, Yan F. Mo D, et al. Cancer Lett. 2019 Aug 10;457:60-73. doi: 10.1016/j.canlet.2019.05.007. Epub 2019 May 9. Cancer Lett. 2019. PMID: 31078732

2

MiRNA-145 suppresses lung adenocarcinoma cell invasion and migration by targeting N-cadherin.

Mo D, Yang D, Xiao X, Sun R, Huang L, Xu J. Mo D, et al. Biotechnol Lett. 2017 May;39(5):701-710. doi: 10.1007/s10529-017-2290-9. Epub 2017 Jan 24. Biotechnol Lett. 2017. PMID: 28120164

3

Identification of tRNA-Derived Fragments Expression Profile in Breast Cancer Tissues.

Wang X, Yang Y, Tan X, Mao X, Wei D, Yao Y, Jiang P, Mo D, Wang T, Yan F. Wang X, et al. Among authors: mo d. Curr Genomics. 2019 Apr;20(3):199-213. doi: 10.2174/1389202920666190326145459. Curr Genomics. 2019. PMID: 31929727 Free PMC article.

4

DCST1-AS1 Promotes TGF-β-Induced Epithelial-Mesenchymal Transition and Enhances Chemoresistance in Triple-Negative Breast Cancer Cells via ANXA1.

Tang L, Chen Y, Chen H, Jiang P, Yan L, Mo D, Tang X, Yan F. Tang L, et al. Among authors: mo d. Front Oncol. 2020 Mar 12;10:280. doi: 10.3389/fonc.2020.00280. eCollection 2020. Front Oncol. 2020. PMID: 32226772 Free PMC article.

5

miR-219a-1 inhibits colon cancer cells proliferation and invasion by targeting MEMO1.

Xu K, Shi J, Mo D, Yang Y, Fu Q, Luo Y. Xu K, et al. Among authors: mo d. Cancer Biol Ther. 2020 Dec 1;21(12):1163-1170. doi: 10.1080/15384047.2020.1843897. Epub 2020 Nov 20. Cancer Biol Ther. 2020. PMID: 33218285 Free PMC article.

6

tRNA-Derived Fragment tRF-17-79MP9PP Attenuates Cell Invasion and Migration via THBS1/TGF-β1/Smad3 Axis in Breast Cancer.

Mo D, He F, Zheng J, Chen H, Tang L, Yan F. Mo D, et al. Front Oncol. 2021 Apr 12;11:656078. doi: 10.3389/fonc.2021.656078. eCollection 2021. Front Oncol. 2021. PMID: 33912465 Free PMC article.

7

Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1.

Tang L, Wei D, Xu X, Mao X, Mo D, Yan L, Xu W, Yan F. Tang L, et al. Among authors: mo d. NPJ Breast Cancer. 2021 Jul 16;7(1):94. doi: 10.1038/s41523-021-00293-x. NPJ Breast Cancer. 2021. PMID: 34272387 Free PMC article.

8

FOXO1-regulated lncRNA CYP1B1-AS1 suppresses breast cancer cell proliferation by inhibiting neddylation.

Tang L, Wei D, Xu X, Mo D, Cheng D, Yan F. Tang L, et al. Among authors: mo d. Breast Cancer Res Treat. 2023 Nov;202(2):397-408. doi: 10.1007/s10549-023-07090-z. Epub 2023 Aug 28. Breast Cancer Res Treat. 2023. PMID: 37640964 Free PMC article.

9

Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer.

Wang X, Chen D, Ma Y, Mo D, Yan F. Wang X, et al. Among authors: mo d. Clin Transl Oncol. 2024 Aug;26(8):1934-1943. doi: 10.1007/s12094-024-03416-5. Epub 2024 Mar 7. Clin Transl Oncol. 2024. PMID: 38451413 Free PMC article.

10

tRNA-derived fragment 3'tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer.

Mo D, Tang X, Ma Y, Chen D, Xu W, Jiang N, Zheng J, Yan F. Mo D, et al. J Transl Med. 2024 Jul 30;22(1):706. doi: 10.1186/s12967-024-05513-z. J Transl Med. 2024. PMID: 39080676 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

793 results

Search Page

Filters